Spots Global Cancer Trial Database for Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer
Official Title: An Open-label, Multi-center, Phase II Study to Evaluate the Activity of Patupilone (EPO906), in the Treatment of Recurrent or Progressive Brain Metastases in Patients With Non-small Cell Lung Cancer.
Study ID: NCT00219297
Interventions
Study Description
Brief Summary: The study objective is to evaluate the safety and efficacy of patupilone with respect to early progression and response of patients with non-small cell lung cancer (NSCLC) metastatic to the brain, who have progressed after chemotherapy, surgery and/or radiation.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of California Davis Cancer Center UC Davis Cancer (3), Sacramento, California, United States
Dana Farber Cancer Institute SC, Boston, Massachusetts, United States
Wayne State University/Wertz Clinical Cancer Center Div. of Hematology/Oncology, Detroit, Michigan, United States
St Louis University Cancer Center, Saint Louis, Missouri, United States
Washington University School of Medicine-Siteman Cancer Ctr, Saint Louis, Missouri, United States
Dartmouth Hitchcock Medical Center Oncology, Lebanon, New Hampshire, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Columbia University Medical Center New York Presbyterian, New York, New York, United States
Duke University Medical Center Dept. of DUMC (3), Durham, North Carolina, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
